These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1514145)

  • 1. [Resistance to antivitamins K].
    Sánchez Villegas JM; Piqueras J; Nicolau I; Picó M; Soler JA; Monasterio J
    Sangre (Barc); 1992 Aug; 37(4):297-8. PubMed ID: 1514145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous warfarin as an alternative for anticoagulation.
    Gellatly RM
    Pharmacotherapy; 2007 Jun; 27(6):933-5. PubMed ID: 17542775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total resistance to oral anticoagulants (nicoumalone and warfarin).
    Danesi MA
    Br J Clin Pract; 1980 Feb; 34(2):55, 64. PubMed ID: 7387825
    [No Abstract]   [Full Text] [Related]  

  • 6. Warfarin resistance: diagnosis and therapeutic alternatives.
    Hulse ML
    Pharmacotherapy; 1996; 16(6):1009-17. PubMed ID: 8947972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary warfarin resistance. Investigation of a rare phenomenon.
    Alving BM; Strickler MP; Knight RD; Barr CF; Berenberg JL; Peck CC
    Arch Intern Med; 1985 Mar; 145(3):499-501. PubMed ID: 3977518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of acenocoumarol in a warfarin-resistant patient with deep venous thrombosis: a case report.
    Marusic S; Gojo-Tomic N; Franic M; Bozina N
    Eur J Clin Pharmacol; 2009 Dec; 65(12):1265-6. PubMed ID: 19652960
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of cerebral infarction in association with free protein S deficiency and oral contraceptive use.
    Lagosky S; Witten CM
    Arch Phys Med Rehabil; 1993 Jan; 74(1):98-100. PubMed ID: 8420528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin resistance associated with intravenous lipid administration: discussion of propofol and review of the literature.
    MacLaren R; Wachsman BA; Swift DK; Kuhl DA
    Pharmacotherapy; 1997; 17(6):1331-7. PubMed ID: 9399621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired warfarin resistance and weight-reducing diet.
    Qureshi GD; Reinders TP; Swint JJ; Slate MB
    Arch Intern Med; 1981 Mar; 141(4):507-9. PubMed ID: 7212893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of methimazole on warfarin anticoagulation in a case of Graves' disease.
    Akin F; Yaylali GF; Bastemir M; Yapar B
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):89-91. PubMed ID: 18180622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol).
    Pattacini C; Manotti C; Pini M; Quintavalla R; Dettori AG
    Thromb Haemost; 1994 Feb; 71(2):188-91. PubMed ID: 8191397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral anticoagulants: warfarin or acenocumarol?].
    Roncalés FJ
    Med Clin (Barc); 2008 Jun; 131(3):98-100. PubMed ID: 18590624
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrent deep venous thrombosis during optimal anticoagulation and overt hyperthyroidism: a case report.
    Squizzato A; Vitale J; Gerdes VE; Romualdi E; Büller HR; Ageno W
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):801-3. PubMed ID: 17982323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal intoxications by acenocoumarol, phenprocoumon and warfarin: method validation in blood using the total error approach.
    Denooz R; Douamba Z; Charlier C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2344-8. PubMed ID: 19144578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulation.
    Poli D; Antonucci E; Lombardi A; Gensini GF; Abbate R; Prisco D
    Haematologica; 2003 Feb; 88(2):237-8. PubMed ID: 12604423
    [No Abstract]   [Full Text] [Related]  

  • 19. Expedited discharge in trauma patients requiring anticoagulation for deep venous thrombosis prophylaxis: the LEAP Program.
    Bridges GG; Lee MD; Jenkins JK; Stephens MA; Croce MA; Fabian TC
    J Trauma; 2003 Feb; 54(2):232-5. PubMed ID: 12579045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial infarction after diet-induced warfarin resistance.
    Walker FB
    Arch Intern Med; 1984 Oct; 144(10):2089-90. PubMed ID: 6486994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.